1. Sun H(#), Huang Q, Huang M, Wen H, Lin R, Zheng M, Qu K, Li K, Wei H, Xiao W, Sun R, Tian Z(*), Sun C(*). Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma. Hepatology. 2018 Nov 8. doi: 10.1002/hep.30347.

2. Sun C(#), Lan P(#), Han Q(#), Huang M, Zhang Z, Xu G, Song J, Wang J, Wei H, Zhang J, Sun R, Zhang C, Tian Z(*). Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nature Communications. 2018 Mar 28;9(1):1241.

3.Sun H(#), Xu J, Huang Q, Huang M, Li K, Qu K, Wen H, Lin R, Zheng M, Wei H, Xiao W, Sun R, Tian Z(*), Sun C(*). Reduced CD160 Expression Contributes to Impaired NK-cell Function and Poor Clinical Outcomes in Patients with HCC. Cancer Res. 2018 Sep 19.CAN-18-1049.

4. Li J, Koch M, Kramer K, Kloth K, Abu Ganim AR, Scheidat S, Rinninger F, Thaiss F, Gulati A, Herden U, Achilles E, Fischer L, Nashan B. Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation. Transpl Immunol. 2018 Jun 6. pii: S0966- 3274(17)30115-6. doi: 10.1016/j.trim.2018.06.001.

1.Sun C(#)(*), Xu J, Huang Q, Huang M, Wen H, Zhang C, Wang J, Song J, Zheng M, Sun H, Wei H, Xiao W, Sun R, Tian Z(*). High NKG2A Expression Contributes to NK Cell Exhaustion and Predicts a Poor Prognosis of Patients with Liver Cancer. Oncoimmunology. Volume 6, 2017 6(1):e1264562.

2.Sun H(#), Song J, Weng C, Xu J, Huang M, Huang Q, Sun R, Xiao W, Sun C(*). Association of decreased expression of the macrophage scavenger receptor MARCO with tumor progression and poor prognosis in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2017 May;32(5):1107-1114.

3. Schütz E, Fischer A, Beck J, Harden M, Koch M, Wuensch T, Stockmann M, Nashan B, Kollmar O, Matthaei J, Kanzow P, Walson PD, Brockmöller J, Oellerich M. Graft-derived cell-free DNA, a non-invasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicentre cohort study. PLoS Med. 2017 Apr 25;14(4):e1002286. doi: 10.1371/journal.pmed.1002286. eCollection 2017 Apr.

4. Lunemann S, Martrus G, Goebels H, Kautz T, Langeneckert A, Salzberger W, Koch M, J Bunders M, Nashan B,van Gisbergen KPJM, Altfeld M. Hobit expression by a subset of human liver-resident CD56bright Natural Killer Cells. Sci Rep. 2017 Jul 27;7(1):6676. doi:10.1038/s41598-017-06011-7.

1. Sun H(#), Xu J, Huang M, Huang Q, Sun R, Xiao W, Sun C(*). CD200R, a co-inhibitory receptor on immune cells, predicts the prognosis of human hepatocellular carcinoma. Immunol Lett. 2016 Oct;178:105-13.

2. Sun C(#), Xu J, Song J, Liu C, Wang J, Weng C, Sun H, Wei H, Xiao W, Sun R, Tian Z(*). The predictive value of centre tumour CD8⁺ T cells in patients with hepatocellular carcinoma: comparison with Immunoscore. Oncotarget. 2015 Nov 3;6(34):35602-15.

3. Sun H(#), Sun C, Tian Z, Xiao W. NK cells in immunotolerant organs. Cell Mol Immunol. 2013 May;10(3):202-12.

4. Sun C(#), Fu B, Gao Y, Liao X, Sun R, Tian Z(*), Wei H(*). TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathogens. 2012;8(3):e1002594.

5. Sun C(#), Sun H, Zhang C, Tian Z(*). NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma. Cell Mol Immunol. 2015 May;12(3):292-302.

6. Sun C(#), Sun HY, Xiao WH, Zhang C, Tian Z(*). Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy. Acta Pharmacol Sin. 2015 Oct;36(10):1191-9.